|
advertisement
|
|
|
|
| Healthcare IT and Biotechnology News Release |
| News Home :: Healthcare IT and Biotechnology News Releases :: More News Releases on this day |
| Date of Publication: Friday, July 11, 2008 |
etrials Worldwide CEO Chip Jennings Resigns |
| etrials Worldwide, Inc. (Nasdaq: ETWC) announced today that Eugene (“Chip”) Jennings has resigned his position as president and chief executive officer |
MORRISVILLE, N.C. -- etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services that optimize clinical trial management by turning data into intelligence and shortening the pathway to an actionable study endpoint, announced today that Eugene (“Chip”) Jennings has resigned his position as president and chief executive officer, and his board seat effective July 8 for family reasons. The board has named Chuck Piccirillo, etrials vice president of technology, interim president and chief executive officer while it conducts a national search for a new chief executive officer. Both internal and external candidates will be considered. Mr. Jennings has agreed to remain available on a consultative basis to facilitate a smooth transition of his responsibilities.
“On behalf of etrials board of directors, I would like to thank Chip for his leadership in setting in motion a major transformation at etrials since joining the company in May of last year,” said Robert Brill, chairman of the board of directors. “Chip leaves the company with an effective sales management team and revitalized sales force, and the entire organization is keenly focused on driving sales of integrated solutions that uniquely address the needs of our customers.
“To Chip’s credit, he also formed a high-caliber senior management team to execute the growth strategy and implement the re-engineering initiatives across the organization,” added Brill. “As a key member of this seasoned executive team, Chuck has spearheaded etrials integrated solutions plans – it’s a cornerstone of the company’s strategy to increase market share and capture opportunities in the growing mid-tier market.”
“I am honored to have the opportunity to lead etrials in implementing our strategy and executing on our growth plans,” said Chuck, interim chief executive officer. “At etrials our number one priority is customer satisfaction, and we are dedicated to helping our customers make the clinical trial process work smarter; providing them with the right solution, backed by powerful tools and consultative expertise, to meet their needs; and delivering high-touch service throughout a clinical trial.”
|
|
| Other News Items Published on the Friday, July 11, 2008 |
|
|